Gene · 4669
NIH grants907
NIH grants whose papers are about the gene, through NIH's grant-paper links.
81 to 100 of 907
Download this page as JSON| Grant | Title | NAGLU papers | Newest fiscal year |
|---|---|---|---|
| R01CA202981 | African-ancestry Breast Cancer Genetic Consortium | 1 | 2025 |
| R01DK130870 | Advanced Kidney Health Monitoring in Persons Hospitalized with Heart Failure | 1 | 2025 |
| R01DK130997 | Mechanisms of diuretic resistance in heart failure | 1 | 2025 |
| R01ES007331 | Mechanisms of Methylmercury Induced Neuronal Toxicity | 1 | 2025 |
| R01ES010563 | Mechanisms of Manganese Neurotoxicity | 1 | 2025 |
| R01ES026033 | Organic-metal mixtures and neurodevelopment | 1 | 2025 |
| R01ES027353 | Role of alveolar macrophage in omega-3 fatty acid amelioration of silica-triggered autoimmunity. | 1 | 2025 |
| R01GM117372 | Chaperone-Assisted Structure Determination of Membrane Proteins | 1 | 2025 |
| R01GM131641 | Mapping endogenous protein dynamics in living cells | 1 | 2025 |
| R01HD020676 | Trophoblast Differentiation | 1 | 2025 |
| R01HD104814 | Enhancement of Newborn Screening Diagnostic Paradigms to Improve the Efficacy of Treatment for Krabbe Disease, Pompe Disease, and Mucopolysaccharidosis Type 1 | 1 | 2025 |
| R01HL084155 | Human Cardiorenal Syndrome | 1 | 2025 |
| R01HL109557 | Mechanisms and Consequences of Gene Induction by Glucocorticoids in Airway Smooth Muscle | 1 | 2025 |
| R01HL151651 | Functional and molecular consequences of SF3B1 mutations in human hematopoietic stem cells | 1 | 2025 |
| R01NS076991 | Oligodendrocyte-focused rAAV gene therapy strategies for Canavan disease and Leukodystrophies | 1 | 2025 |
| R01NS092823 | The role of a-synuclein accumulation in lysosomal hydrolase trafficking and function | 1 | 2025 |
| R01NS124655 | Characterizing and testing the efficacy of AAV-mediated gene therapy in a sheep model of CLN1 disease. | 1 | 2025 |
| R16GM149473 | The Impact of Combined Exposure to Metals and Per- and Polyfluoroalkyl Substances on Stress, Cardiovascular Disease Risk and Mortality | 1 | 2025 |
| R25CA023944 | PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | 1 | 2025 |
| R35GM122481 | Development and Testing of New Computational Methods for Ligand Discovery and Mechanism | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4669/grants?page=5